How Pfizer’s AI and Precision Oncology Deals At Pfizer (PFE) Have Changed Its Investment Story

In early January 2026, Pfizer Inc. and Boltz, PBC announced a collaboration to apply biomolecular AI foundation models to Pfizer’s historical R&D data, while a separate multi-year deal with ...

Boltz Bags $28M Funding and Pfizer Partnership for Biomolecular AI Boost

The partnership brings together Pfizer’s scientific data and therapeutic expertise with Boltz’s open-source AI foundation models.

Boltz and Pfizer Announce Strategic Collaboration to Develop and Deploy State-of-the-Art Biomolecular AI Foundation Models

CAMBRIDGE, Mass., Jan. 8, 2026 /PRNewswire/ -- Pfizer Inc. and Boltz, PBC, an applied AI research lab, today announced a strategic collaboration to empower scientists across the company with ...

Pfizer collaborating with Boltz to use AI models for drug discovery

Pfizer (PFE) has entered into an agreement with Boltz to use the latter's biomolecular AI foundation models to tap into the former's historical data "to create state-of-the-art, exclusive models for ...